rheumatoid arthriitis
Mycenax’s Actemra biosimilar edges closer to approval
George Underwood
biosimilars, rheumatoid arthriitis, Roche
0 Comment
X
Mycenax’s Actemra biosimilar edges closer to approval
https://pharmaphorum.com/news/mycenaxs-actemra-biosimilar-edges-closer-to-approval/
RA pill setback spoils Lilly’s growth story
Andrew McConaghie
Eli Lilly, rheumatoid arthriitis
0 Comment
X
RA pill setback spoils Lilly’s growth story
https://pharmaphorum.com/news/ra-pill-setback-spoils-lillys-growth-story/
AbbVie looks beyond Humira as RA pill meets phase 3 targets
Richard Staines
AbbVie, Eli Lilly, Pfizer, rheumatoid arthriitis
0 Comment
Upadacitinib hopes drug will reduce reliance on Humira.
X
AbbVie looks beyond Humira as RA pill meets phase 3 targets
https://pharmaphorum.com/news/abbvie-looks-beyond-humira-ra-pill-meets-phase-3-targets/